Cambridge Newswire

Comprehensive Real-Time News Feed for Cambridge, MA.

Results 1 - 20 of 59 for "u:bloomberg.com" in Cambridge, MA

  1. Cancer Therapy Boosts Appeal of Juno, Kite as Targets: Real M&ARead the original story

    Tuesday Jun 23 | The Washington Post

    Juno Therapeutics Inc., Kite Pharma Inc., Bluebird Bio Inc. and Cellectis SA are among firms working on CAR T, a gene therapy that supercharges the immune system. They may prove enticing to large drugmakers, even if questions persist about whether promising results from small trials can be widely replicated.

    Comment?

  2. Former Sanofi CEO Reinvents Himself With Bertarelli FundRead the original story

    Tuesday Jun 23 | The Washington Post

    Viehbacher, the former chief executive of France's largest drugmaker, will run Swiss billionaire Ernesto Bertarelli's U.S. based Gurnet Point Capital fund, according to a statement. He has also joined the board of the technology transfer company PureTech Health Plc, which raised $171 million in an initial public offering on the London Stock Exchange this month.

    Comment?

  3. Former Sanofi CEO Makes Science Comeback With Bertarelli FundRead the original story

    Tuesday Jun 23 | The Washington Post

    Viehbacher, the former chief executive at France's largest drugmaker, will run Swiss billionaire Ernesto Bertarelli's U.S. based Gurnet Point Capital fund, according to an e-mailed statement Tuesday. He has also joined the board of the healthcare solutions company PureTech Health Plc, which raised $171 million in an initial public offering on the London Stock Exchange this month.

    Comment?

  4. Chinese Lead Foreign U.S. Home Purchases for First TimeRead the original story

    Wednesday Jun 17 | Bloomberg

    Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. Chinese buyers topped Canadians to rank as the biggest foreign purchasers of U.S. homes by both sales and dollar volume, accounting for more than a quarter of all international spending.

    Comment?

  5. Synergy Soars as Drug That May Spur Buyout Beat ExpectationsRead the original story

    Wednesday Jun 17 | The Washington Post

    In a trial of 1,346 patients with chronic idiopathic constipation, 21 percent responded to plecanatide at a 3- milligram dose, compared with 10 percent given a placebo, the New York-based company said in a statement on Wednesday. The chief side effect of diarrhea was experienced by 5.9 percent of patients at that dose, a far lower rate than analysts expected.

    Comment?

  6. FDA to Work With Online Patient Forum to Mine Safety DataRead the original story

    Monday Jun 15 | The Washington Post

    The FDA is tapping into a broad flow of data sent to PatientsLikeMe, an online site with 350,000 members that says it's the largest and most active patient network online. Members often report their drug-use experiences, symptoms and hospitalizations on the site.

    Comment?

  7. FDA to Work With Online Patient Forum to Mine Drug Safety DataRead the original story w/Photo

    Monday Jun 15 | Bloomberg

    The U.S. Food and Drug Administration is turning to a patient-networking website to get a better handle on the side effects of medications. The FDA is tapping into a broad flow of data sent to PatientsLikeMe , an online site with 350,000 members that says it's the largest and most active patient network online.

    Comment?

  8. Dwyane Wade Goes to HarvardRead the original story w/Photo

    Friday Jun 12 | The Washington Post

    Dwyane Wade #3 of the Miami Heat looks on during a game against the Sacramento Kings at American Airlines Arena on Feb. 21, 2012 in Miami. LeBron James looks as if he's having a pretty intense time playing in the NBA Finals, but in the meantime, former teammate Dwyane Wade is having a moment of his own.

    Comment?

  9. Scariest U.S. Housing Chart Shows Nasty Scar Years After BustRead the original story

    Thursday Jun 11 | Bloomberg

    A decade after U.S. home sales peaked, 15.4 percent of owners in the first quarter owed more on their mortgages than their properties were worth, according to a report Friday by Zillow Inc. While that's down from a high of 31.4 percent in 2012, it's still alarmingly above the 1 or 2 percent that marks a healthy market, said Humphries, the chief economist at the Seattle-based real-estate data provider. Worse yet: The pace of healing is losing steam.

    Comment?

  10. Roche Takes Another Shot at Alzheimer's After Biogen SuccessRead the original story

    Tuesday Jun 9 | The Washington Post

    Roche stopped a trial of gantenerumab in December because patients weren't benefiting more than those receiving a placebo. Four months later, Biogen said that its drug slowed the progression of the disease, supporting a long-held hypothesis that targeting a protein linked to the telltale plaques found in the brains of Alzheimer's patients may yield a treatment.

    Comment?

  11. Roche Takes Another Shot at Alzheimer's After Biogen Has SuccessRead the original story w/Photo

    Monday Jun 8 | Bloomberg

    An impression of a healthy brain in comparison to a brain with advanced Alzheimer's disease. Source: National Institute on Aging/National Institutes of Health via Bloomberg Roche Holding AG is weighing a second test for an experimental Alzheimer's drug that failed in an initial study, after a similar offering from Biogen Inc. showed promise in slowing the memory-robbing ailment.

    Comment?

  12. Bond Rout Wipes Out 2015 Gains as Traders Stay Glued to ScreensRead the original story

    Wednesday Jun 3 | The Washington Post

    Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. The global bond market selloff has erased all of this year's gains as historic market moves from Germany to the U.S. and Japan whipsaw traders.

    Comment?

  13. Paulson Gives Harvard Record $400 Million for EngineeringRead the original story

    Wednesday Jun 3 | The Washington Post

    Harvard said it will rename the engineering school after Paulson and establish an endowment to benefit research, faculty development and financial aid. The gift, one of the largest in the history of higher education, shows how the wealthiest U.S. universities are attracting more than their share of philanthropy.

    Comment?

  14. Bond Rout Wipes Out 2015 GainsRead the original story

    Wednesday Jun 3 | Bloomberg

    Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. The global bond market selloff has erased all of this year's gains as historic market moves from Germany to the U.S. and Japan whipsaw traders.

    Comment?

  15. 10 Career Tips for Today's Graduates from EconomistsRead the original story w/Photo

    May 22, 2015 | Bloomberg

    Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. Millennials, America's favorite generation to hate, have racked up a lot of problems since the last recession.

    Comment?

  16. Fertility Drugmaker OvaScience Up 5.5% on Pregnancy ResultsRead the original story

    May 15, 2015 | The Washington Post

    The Cambridge, Massachusetts-based company jumped $1.52 to $29.17, a three-week high, at the close in New York. The stock has fallen 45 percent since a peak on March 24. Pregnancy rates improved for women using an OvaScience treatment called Augment, which tries to fortify eggs for embryo development with cell structures from the ovary lining, according to the company.

    Comment?

  17. Biogen Drops as Profit Disappoints Amid Slow Tecfidera SalesRead the original story

    Apr 24, 2015 | The Washington Post

    Earnings excluding one-time items rose to $3.82 a share from $2.47 a year earlier. Analysts had forecast $3.88 on average, according to estimates compiled by Bloomberg.

    Comment?

  18. Biogen Profit Trails Estimates as Tecfidera Growth SlowsRead the original story

    Apr 24, 2015 | The Washington Post

    Earnings excluding one-time items rose to $3.82 a share from $2.47 a year earlier. Analysts had forecast $3.88 on average, according to estimates compiled by Bloomberg.

    Comment?

  19. Silicon Valley, then vs. nowRead the original story w/Photo

    Apr 23, 2015 | Bloomberg

    Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. Mark Zuckerberg and Chris Hughes, creators of Facebook, at Eliot House at Harvard University in Cambridge, Mass., on May 14, 2004.

    Comment?

  20. Jack Welch: Fire Someone With DignityRead the original story w/Photo

    Apr 21, 2015 | Bloomberg

    Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. Jack and Suzy Welch discuss their book "The Real-Life MBA: Your No-BS Guide to Winning the Game, Building a Team, and Growing Your Career."

    Comment?

Cambridge Job Listings
View or post Cambridge job listings on Topix.
Cambridge Real Estate
News, listings, and foreclosures in Cambridge from Topix.
Cambridge Mortgages
Find mortgage rates in Cambridge on Topix.